Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.57 |
| ▸ | CA1 | P00915 | 3/20 | 0.57 |
| ▸ | CA9 | Q16790 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | JAK2 | O60674 | 1/20 | 0.51 |
| ▸ | TYK2 | P29597 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.51 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.50 |
| ▸ | PLOD3 | O60568 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | PLOD1 | Q02809 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6499731 | 0.84 | GAA (0.57) | GAACA1CA9ALDH1A1HPGD | |
| SCHEMBL6502042 | 0.84 | CA1 (0.59) | GAACA1CA9ALDH1A1HPGD | |
| SCHEMBL6502761 | 0.84 | KMT2A (0.54) | GAACA1CA9ALDH1A1HTT | |
| SCHEMBL2986200 | 0.82 | ALDH1A1 (0.83) | GAACA1CA9ALDH1A1HTT | |
| SCHEMBL9825195 | 0.79 | RAB9A (0.61) | GAACA1CA9ALDH1A1MEN1 | |
| SCHEMBL2992964 | 0.74 | ALDH1A1 (1.00) | GAACA1CA9ALDH1A1CYP1A2 | |
| SCHEMBL9131717 | 0.74 | ALDH1A1 (0.63) | GAACA1CA9ALDH1A1MEN1 | |
| SCHEMBL14526874 | 0.73 | CTDSP1 (0.75) | GAACA1CA9ALDH1A1JAK2 | |
| SCHEMBL250413 | 0.73 | PTGS2 (0.75) | GAACA1CA9ALDH1A1HTT | |
| Pyridine SCHEMBL28224544 | 0.72 | CA1 (0.75) | GAACA1CA9ALDH1A1JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050222423-A1 | Carboxylic acid derivative | TAISHO PHARMECEUTICAL CO., LTD. (JP) | 2005-10-06 | — | — | US | disclosed |
| EP-1466891-A1 | CARBOXYLIC ACID DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2004-10-13 | — | — | EP | disclosed |
| WO-2002043668-A2 | ANTIMYCOBACTERIAL COMPOUNDS AND METHOD FOR MAKING THE SAME | WELLESLEY COLLEGE (US) | 2002-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050222423-A1 | Carboxylic acid derivative | KDR, FLT1, FLT4 | GAA 2442/4885CA1 803/4885CA9 313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.